Gralow J - Search Results

1

A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338.

Chew HK, Barlow WE, Albain K, Lew D, Gown A, Hayes DF, Gralow J, Hortobagyi GN, Livingston R. Chew HK, et al. Among authors: gralow j. Clin Breast Cancer. 2008 Dec;8(6):511-5. doi: 10.3816/CBC.2008.n.062. Clin Breast Cancer. 2008. PMID: 19073506 Free PMC article. Clinical Trial.

2

Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy.

Mankoff DA, Dunnwald LK, Gralow JR, Ellis GK, Charlop A, Lawton TJ, Schubert EK, Tseng J, Livingston RB. Mankoff DA, et al. Among authors: gralow jr. J Nucl Med. 2002 Apr;43(4):500-9. J Nucl Med. 2002. PMID: 11937594 Free article.

3

Use of serial FDG PET to measure the response of bone-dominant breast cancer to therapy.

Stafford SE, Gralow JR, Schubert EK, Rinn KJ, Dunnwald LK, Livingston RB, Mankoff DA. Stafford SE, et al. Among authors: gralow jr. Acad Radiol. 2002 Aug;9(8):913-21. doi: 10.1016/s1076-6332(03)80461-0. Acad Radiol. 2002. PMID: 12186440

4

Dose-dense anthracycline-based chemotherapy for node-positive breast cancer.

Ellis GK, Livingston RB, Gralow JR, Green SJ, Thompson T. Ellis GK, et al. Among authors: gralow jr. J Clin Oncol. 2002 Sep 1;20(17):3637-43. doi: 10.1200/JCO.2002.12.113. J Clin Oncol. 2002. PMID: 12202664 Clinical Trial.

5

[Tc-99m]-sestamibi uptake and washout in locally advanced breast cancer are correlated with tumor blood flow.

Mankoff DA, Dunnwald LK, Gralow JR, Ellis GK, Schubert EK, Charlop AW, Tseng J, Rinn KJ, Livingston RB. Mankoff DA, et al. Among authors: gralow jr. Nucl Med Biol. 2002 Oct;29(7):719-27. doi: 10.1016/s0969-8051(02)00333-5. Nucl Med Biol. 2002. PMID: 12381452 Clinical Trial.

6

American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer.

Hillner BE, Ingle JN, Chlebowski RT, Gralow J, Yee GC, Janjan NA, Cauley JA, Blumenstein BA, Albain KS, Lipton A, Brown S; American Society of Clinical Oncology. Hillner BE, et al. Among authors: gralow j. J Clin Oncol. 2003 Nov 1;21(21):4042-57. doi: 10.1200/JCO.2003.08.017. Epub 2003 Sep 8. J Clin Oncol. 2003. PMID: 12963702

7

Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy.

Mankoff DA, Dunnwald LK, Gralow JR, Ellis GK, Schubert EK, Tseng J, Lawton TJ, Linden HM, Livingston RB. Mankoff DA, et al. Among authors: gralow jr. J Nucl Med. 2003 Nov;44(11):1806-14. J Nucl Med. 2003. PMID: 14602864 Free article.

8

HER-2 testing in breast cancer using parallel tissue-based methods.

Yaziji H, Goldstein LC, Barry TS, Werling R, Hwang H, Ellis GK, Gralow JR, Livingston RB, Gown AM. Yaziji H, et al. JAMA. 2004 Apr 28;291(16):1972-7. doi: 10.1001/jama.291.16.1972. JAMA. 2004. PMID: 15113815

9

Impact of FDG PET on defining the extent of disease and on the treatment of patients with recurrent or metastatic breast cancer.

Eubank WB, Mankoff D, Bhattacharya M, Gralow J, Linden H, Ellis G, Lindsley S, Austin-Seymour M, Livingston R. Eubank WB, et al. Among authors: gralow j. AJR Am J Roentgenol. 2004 Aug;183(2):479-86. doi: 10.2214/ajr.183.2.1830479. AJR Am J Roentgenol. 2004. PMID: 15269044

10

Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC).

Bellon JR, Livingston RB, Eubank WB, Gralow JR, Ellis GK, Dunnwald LK, Mankoff DA. Bellon JR, et al. Am J Clin Oncol. 2004 Aug;27(4):407-10. doi: 10.1097/01.coc.0000128869.19357.9b. Am J Clin Oncol. 2004. PMID: 15289736

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

281 results

Search Page

Filters